Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24616506.
- Also identified by DOI 10.1073/pnas.1402714111 and PMC identifier 3970508.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
MicroRNAs (miRNAs) are small, noncoding RNAs that regulate gene expression and, in cancers, are often packaged within secreted microvesicles. The cachexia syndrome is a debilitating state of cancer that predominantly results from the loss of skeletal muscle mass, which is in part associated with apoptosis. How tumors promote apoptosis in distally located skeletal muscles has not been explored. Using both tumor cell lines and patient samples, we show that tumor-derived microvesicles induce apoptosis of skeletal muscle cells. This proapoptotic activity is mediated by a microRNA cargo, miR-21, which signals through the Toll-like 7 receptor (TLR7) on murine myoblasts to promote cell death. Furthermore, tumor microvesicles and miR-21 require c-Jun N-terminal kinase activity to regulate this apoptotic response. Together, these results describe a unique pathway by which tumor cells promote muscle loss, which might provide a great insight into elucidating the causes and treatment options of cancer cachexia.
Medical subject headings
- Apoptosis
- Cachexia
- MicroRNAs
- Muscle, Skeletal
- Neoplasms
- Organelles
- Toll-Like Receptor 7